Publications

  1. Demers LM: The effects of fadrozole (CGS 19949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients. Breast Cancer Treatment Report on Aromatase and Breast Cancer, 30(1):95-102,1994.
  2. Kulin H, Demers L, Chinchilli V, Martel J, Stevens L: Usefulness of sequential urine FSH and LH measurements in the diagnosis of adolescent-aged hypogonadotropism. J Clin Endo & Metab. 78(5):1208-1212, 1994.
  3. DeSouza M J, Luciano M, Arce JC, Demers LM, Loucks AB: Clinical tests explain blunted cortisol responsiveness but not mild hypercortisolism in amenorrheic nnners. J Appl. Physiol. 76(3):1302-1309, 1994.
  4. Malarkey WB, Hall JC, Rice RR, O'Toole ML, Douglas PS, Demers LM, Glaser R: The influence of age on endocrine responses to ultraendurance stress. J. Gerontology, 48(4) :M 1 34-M 139, 1993.
  5. Lipton A, Demers L, Daniloff Y, Curley E, Hamilton C, Harvey H, Witters L, Seaman J, Van der Giessen R, Seyedin S: Increased urinary excretion of pyridinium crosslinks in cancer patients. Clin Chem 39(4):614-618,1993 .
  6. Demers LM, Lipton A, Harvey HA, Hanagan J, Mulagha M, Santen RJ: The effects of long-term fadrozole hydrochloride treatment in patients with advanced stage breast cancer. J. Steroid Biochem. Molec. Biol. 44(4-6), pp 683-685, 1993.
  7. Demers LM, Lipton A, Harvey HA, Kambic KB, Grossberg H, Brady C, Santen RJ: The efficacy of CGS 20267 in suppressing estrogen biosynthesis in patients with advanced stage breast cancer. J. Steroid Biochem. Molec. Biol. 44(4-6), pp 687-691,1993.
  8. Malarkey WB, Strauss RH, Leizman DJ, Liggett M, and Demers LM: Endocrine effects in women weight lifters self administering testosterone and anabolic steroids. Am. J. OB/GYN 165:1385-1390, 1991.
  9. Lloyd T, Schaeffer JM, Walker MA, and Demers LM: Urinary hormonal concentrations and spinal bone densities of premenopausal vegetarian and non-vegetarian women. Amer J. Clin. Nutrition, 54(6) :1005-1010, 1991.
  10. 1Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ: Clinical and biochemical parameters of androgen action in normal healthy Caucasian vs. Chinese subjects. J. Clin Endo & Metab., 72:1242-1248,1991.
  11. 1Santen RJ, Demers LM, Lynch J, Harvey H, Lipton A, Mulagha M, Hanagan J, Garber JE, Henderson IC, Navari RM, and Miller M: Specificity of low dose fadrozole (CGS 1 6949A) as an aromatase inhibitor. J. Clin Endo & Metab 73:99-106,1991.
  12. 1Kochak GM, Mangat S, Mulagha MT, Entwistle, Santen RJ, Lipton A, and Demers LM: The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition. J. Clin Endo and Metab Vol 71 (5), pp 1349 - 55, 1990.
  13. 1Lipton A, Harvey HA, Demers LM, Hanagan JR, Mulagha MT, Kochak GM, Fitzsimmons S, Sanders Sl, and Santen RJ: A phase I trial of CGS 16949A: A new aromatase inhibitor. Cancer 65:1279-1285, 1990.
  14. Ahmed SR, Boucher AE, Manni A, Santen RJ, and Demers LM: Transdermal testosterone therapy in the treatment of male hypogonadism. J. Clin Endo and Metab. Vol 66(3), p546-551, 1990.
  15. Demers LM, Melby JC, Wilson TE, Lipton A, Harvey HA, and Santen RJ: The effects of CGS 16949A, an aromatase inhibitor on adrenal mineralocorticoid biosynthesis. J Clin Endo Metab 70:1162-1166, 1990.
  16. Buchanan JR, Myers C, Lloyd T, Leuenberger P, and Demers LM: Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise. J. Bone Mineral Research 3:673-680,1988.
  17. Buchanan JR, Hospodar P, Myers C, Leuenberger P, and Demers LM: Effect of excess endogenous androgens on bone density in young women. J. Clin Endo Metab. Vol 67, No 5, pp 986-991, 1988.
  18. Demers LM, Harvey HA, Glenn JD, and Gaur PK: A new tumor marker for patients with advanced breast cancer. J.Clin Lab Analysis Vol 2, No 3, pp 168-173,1988.
  19. Lloyd T, Myers C, Buchanan JR, and Demers LM: Collegiate women athletes with irregular menses during adolescence have decreased bone density. Ob Gyn Vol 72, No. 4, pp 639-642, 1988.
  20. Baker E. and Demers LM: Menstrual status in female athletes: Correlation with reproductive hormones and bone density. Obstet. Gynec. Vol 72, No. 5, pp 683-687,